|
Title (Click for Abstract / Details) | Author | Issue | Page | View/Buy |
| PreScription: Compounding for Drug Shortages | Allen Loyd V Jr | May/Jun 2013 | 180 | Buy |
| Complying with Occupational Safety and Health Administration Regulations: A Guide for Compounding Pharmacists | Mixon Bill, Nain John | May/Jun 2013 | 182-190 | Buy |
| Decontamination Technology: The Missing Element | Rahe Hank | May/Jun 2013 | 193-199 | Buy |
| Optimizing Third-party Reimbursement for Compounded Medications | McElhiney Linda F | May/Jun 2013 | 201-204 | Buy |
| International Academy of Compounding Pharmacists' Legislative/Regulatory Update | Miller David G | May/Jun 2013 | 206 | Buy |
| Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations | Allen Loyd V Jr | May/Jun 2013 | 210-219 | Buy |
| Basics of Compounding: Potency and Stability Testing | Allen Loyd V Jr | May/Jun 2013 | 220-224 | Buy |
| Calculations | Stockton Shelly J | May/Jun 2013 | 226 | Buy |
| Buffered Aspirin Capsules | Allen Loyd V Jr | May/Jun 2013 | 228 | Buy |
| Calcium Acetate 667-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 229 | Buy |
| Estradiol 0.5-mg, 1-mg, or 2-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 230 | Buy |
| Ethambutol 400-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 231 | Buy |
| Isoniazid 300-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 232 | Buy |
| Labetalol 50-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 233 | Buy |
| Mercaptopurine 75-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 234 | Buy |
| Naltrexone Hydrochloride 50-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 235 | Buy |
| Prednisone 10-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 236 | Buy |
| Reserpine 0.5-mg Capsules | Allen Loyd V Jr | May/Jun 2013 | 237 | Buy |
| Assessing the Stability of Common Radiopharmaceuticals Compounded and Utilized Outside Package Insert Guidelines | Weatherman Kara D, Augustine Samuel,Christoff Jeffrey, Galbraith Wendy | May/Jun 2013 | 238-246 | Buy |
| Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel | Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott | May/Jun 2013 | 247-253 | Buy |
| Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline | Klemmer Anja, Krämer Irene, Kamin Wolfgang | May/Jun 2013 | 254-261 | Buy |
| PostScription: The Pharmacist's Role in the Treatment of Cancer: A Personal Plea and Testimonial | Williams LaVonn A | May/Jun 2013 | 262-263
|
No comments:
Post a Comment